Biopharmaceutical innovation is revolutionizing medical treatment and has ushered in a new era of medicine for patients. With nearly 7,000 medicines in development, 74 percent of which are potentially first-in-class, patients have more reasons to be optimistic than ever before. Medicines are being developed across dozens of therapeutic areas – including cancer, diabetes, cardiovascular, Alzheimer’s disease and more. Find out more about the potential of the biopharmaceutical R&D pipeline below.